[DPHARMA] YoY Quarter Result on 31-Mar-2014 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
20-May-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Mar-2014 [#1]
Profit Trend
QoQ- -10.18%
YoY- 24.87%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 120,994 79,470 45,599 40,495 37,837 36,057 32,984 24.16%
PBT 11,176 9,941 12,198 11,175 8,956 8,869 7,875 6.00%
Tax -2,558 -2,113 -3,229 -2,810 -2,257 -2,161 -1,951 4.61%
NP 8,618 7,828 8,969 8,365 6,699 6,708 5,924 6.44%
-
NP to SH 8,618 7,843 8,969 8,365 6,699 6,708 5,924 6.44%
-
Tax Rate 22.89% 21.26% 26.47% 25.15% 25.20% 24.37% 24.77% -
Total Cost 112,376 71,642 36,630 32,130 31,138 29,349 27,060 26.75%
-
Net Worth 463,071 457,492 205,045 190,050 176,143 170,824 162,320 19.07%
Dividend
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Div - - - - - - - -
Div Payout % - - - - - - - -
Equity
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Net Worth 463,071 457,492 205,045 190,050 176,143 170,824 162,320 19.07%
NOSH 278,959 278,959 139,486 138,723 138,695 138,881 138,735 12.33%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 7.12% 9.85% 19.67% 20.66% 17.70% 18.60% 17.96% -
ROE 1.86% 1.71% 4.37% 4.40% 3.80% 3.93% 3.65% -
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 43.37 28.49 32.69 29.19 27.28 25.96 23.77 10.53%
EPS 3.43 2.81 6.43 6.03 4.83 4.83 4.27 -3.58%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 1.66 1.64 1.47 1.37 1.27 1.23 1.17 5.99%
Adjusted Per Share Value based on latest NOSH - 138,723
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 12.57 8.26 4.74 4.21 3.93 3.75 3.43 24.14%
EPS 0.90 0.81 0.93 0.87 0.70 0.70 0.62 6.40%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 0.481 0.4752 0.213 0.1974 0.183 0.1775 0.1686 19.07%
Price Multiplier on Financial Quarter End Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 -
Price 2.31 2.55 3.88 3.03 2.23 2.40 2.35 -
P/RPS 5.33 8.95 11.87 10.38 8.17 9.24 9.88 -9.76%
P/EPS 74.77 90.70 60.34 50.25 46.17 49.69 55.04 5.23%
EY 1.34 1.10 1.66 1.99 2.17 2.01 1.82 -4.97%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 1.39 1.55 2.64 2.21 1.76 1.95 2.01 -5.95%
Price Multiplier on Announcement Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 22/05/17 18/05/16 18/05/15 20/05/14 27/05/13 17/05/12 25/05/11 -
Price 2.32 2.40 3.90 3.09 2.51 2.38 2.57 -
P/RPS 5.35 8.42 11.93 10.59 9.20 9.17 10.81 -11.05%
P/EPS 75.10 85.36 60.65 51.24 51.97 49.28 60.19 3.75%
EY 1.33 1.17 1.65 1.95 1.92 2.03 1.66 -3.62%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 1.40 1.46 2.65 2.26 1.98 1.93 2.20 -7.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment